PA
TEVA icon

Procyon Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Procyon Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-210
Closed -$3K – 963
2020
Q2 		$3K Hold
210
– – ﹤0.01% 883
2020
Q1 		$2K Buy
+210
New +$2.15K ﹤0.01% 871

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Procyon Advisors's TEVA Position: Q3 2020 in Review

Procyon Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2020, closing a stake of 210 shares — an estimated $3K sold.

Procyon Advisors first reported a position in TEVA in Q1 2020 and held it in 2 quarters. The position peaked at $3K in Q2 2020. 444 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Procyon Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2020 after selling out during the quarter.
  • Procyon Advisors sold 210 Teva Pharmaceutical Industries Limited shares in Q3 2020, an estimated $3K.
  • Procyon Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and held it in 2 quarters.
  • Procyon Advisors's Teva Pharmaceutical Industries Limited position peaked at $3K in Q2 2020.
  • 444 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.